Should You Add CTI BioPharma Corp (CTIC) Stock to Your Portfolio Monday?

Monday, May 15, 2023 01:36 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add CTI BioPharma Corp (CTIC) Stock to Your Portfolio Monday?

A rating of 83 puts CTI BioPharma Corp (CTIC) near the top of the Healthcare sector according to InvestorsObserver. CTI BioPharma Corp's score of 83 means that it ranks higher than 83% of stocks in the sector. In addition, its overall score of 99 ranks it higher than 99% of all stocks.

CTIC has an Overall Score of 99. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 99 means the stock is more attractive than 99 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With CTI BioPharma Corp Stock Today?

CTI BioPharma Corp (CTIC) stock is down -0.39% while the S&P 500 has risen 0.31% as of 1:21 PM on Monday, May 15. CTIC is down -$0.03 from the previous closing price of $8.96 on volume of 5,985,300 shares. Over the past year the S&P 500 has gained 3.21% while CTIC has risen 98.44%. CTIC lost -$0.81 per share the over the last 12 months. Click Here to get the full Stock Report for CTI BioPharma Corp stock.